Discovery on Target 2026
Visit Booth 403 to connect with our team.
WuXi AppTec is pleased to participate in Discovery on Target 2026, taking place September 28–October 1, 2026, in Boston, Massachusetts. For more than 20 years, Discovery on Target has brought together scientists, technology innovators, and drug discovery leaders to explore advances across emerging drug targets, novel therapeutic modalities, lead generation strategies, and innovative discovery technologies.
As drug discovery continues to expand toward increasingly complex targets and diverse therapeutic modalities, access to integrated scientific expertise and advanced discovery technologies is critical. WuXi AppTec supports innovators with comprehensive drug discovery solutions spanning target identification and validation, assay development, screening, hit identification, lead generation and optimization, and preclinical development. Our integrated platform combines deep scientific expertise with advanced technologies to help researchers address challenging targets, accelerate the discovery process, and efficiently advance promising therapeutic candidates.
Our scientists will present two talks highlighting advances in targeted protein degradation and oligonucleotide conjugates:
- Exploration of Novel E3 Ligase to Support Targeted Protein Degradation Drug Discovery
- Integrated Platform to Accelerate Drug Discovery on Oligonucleotide Conjugates
To schedule a dedicated meeting with our team, please fill out the brief form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
Research Chemistry Services
Resource Type: Brochure
